Edward Zheng

Mr. Edward Zheng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EZEdward Zheng
Edward Zheng
IWIzabela Warchoł
Izabela Warchoł
MMMaja Mejza
Maja Mejza
MMMaria Możdżan
Maria Możdżan
MSMonika Strzemińska
Monika Strzemińska
MPMichał Plewka
Michał Plewka
Inflammation has been widely recognized as one of the major pathophysiological drivers of the development of atrial fibrillation (AF), which works in tandem with other risk factors of AF including obesity, diabetes, hypertension, and heart failure (HF). Our current understanding of the role of inflammation in the natural history of AF remains elusive; however, several key players, including the NLRP3 (NLR family pyrin domain containing 3) inflammasome, have been acknowledged to be heavily influential on chronic inflammation in the atrial myocardium, which leads to fibrosis and eventual degradation of its electrical function. Nevertheless, our current methods of pharmacological modalities with reported immunomodulatory properties, including well-established classes of drugs e.g., drugs targeting the renin–angiotensin–aldosterone system (RAAS), statins, and vitamin D, have proven effective in reducing the overall risk of developing AF, the onset of postoperative atrial fibrillation (POAF), and reducing overall mortality among patients with AF. This might bring hope for further progress in developing new treatment modalities targeting cellular checkpoints of the NLRP3 inflammasome pathway, or revisiting other well-known anti-inflammatory drugs e.g., colchicine, vitamin C, nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticosteroids, and antimalarial drugs. In our review, we aim to find relevant upstream anti-inflammatory treatment methods for the management of AF and present the most current real-world evidence of their clinical utility.

12 August 2024 in Cancers
Verified
Journal Article
Open access
PDF file
ADAgata Dutkowska
Agata Dutkowska
DDDaria Medical of Domańska-Senderowska
Daria Medical of Domańska-Senderowska
KCKarolina Henryka Czarnecka-Chrebelska
Karolina Henryka Czarnecka-Chrebelska
EPEwa Pikus
Ewa Pikus
AZAleksandra Zielińska
Aleksandra Zielińska
MPMichał Poznański
Michał Poznański
In lung cancer patients, two complementary abnormalities were found that can cause disruption of the mitochondrial network: increased fusion and impaired fission, manifested by reduced levels of FIS1, a mitochondrial division regulator, and increased expression of MFN1, a mitochondrial fusion mediator. Immunoexpression studies of MFN1 and FIS1 proteins were performed in serum samples obtained from 47 patients with non-small cell lung cancer (NSCLC) and 21 controls. In the NSCLC patients, the immunoexpression of the MFN1 protein was significantly higher, and the FIS1 protein level was significantly lower than in the control group (p < 0.01; p < 0.001; UMW test). Patients with early, operable lung cancer had significantly lower levels of MFN1 immunoexpression compared to patients with advanced, metastatic lung cancer (p < 0.05; UMW test). This suggests that early stages of the disease are characterized by greater fragmentation of damaged mitochondria and apoptosis. In contrast, lower FIS1 protein levels were associated with a worse prognosis. Increased mitochondrial fusion in the blood of lung cancer patients may suggest an increase in protective and repair mechanisms. This opens up questions about why these mechanisms fail in the context of existing advanced cancer disease and is a starting point for further research into why protective mechanisms fail in lung cancer patients.

18 March 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AOAgnieszka Olejnik
Agnieszka Olejnik
MZMateusz Zdaniewicz
Mateusz Zdaniewicz
JAJakub Adamiak
Jakub Adamiak
MMMichał Maciejowski
Michał Maciejowski
BCBartłomiej Czyżak
Bartłomiej Czyżak
EZEdward Zheng
Edward Zheng
Aim: This narrative review aimed to analyze the impact of beta-adrenoceptor antagonists on the physiological response to exercise and to identify clinical implications for exercise training prescription and exercise-based rehabilitation in patients receiving long-term pharmacotherapy. Material and Methods: A structured literature search was conducted in PubMed, Embase, and the Cochrane Library for studies published between January 2018 and February 2026. Randomized controlled trials, crossover studies, observational research, and relevant systematic reviews evaluating the effects of cardioselective and non-selective beta-adrenoceptor antagonists on peak oxygen uptake (VO₂peak), heart rate response, and ventilatory thresholds in healthy and clinical populations were included. Due to heterogeneity in study design, populations, and pharmacological regimens, findings were synthesized narratively without quantitative meta-analysis. Results: Beta-adrenoceptor antagonists consistently attenuate the chronotropic response to exercise, typically reducing maximal heart rate by approximately 18–19%. Despite this effect, VO₂peak and maximal power output are often preserved through compensatory mechanisms such as increased stroke volume and enhanced arteriovenous oxygen extraction. Under beta-blockade, the relationship between heart rate and external workload becomes blunted, limiting the reliability of heart rate–based methods (e.g., %HRmax, HRR) for exercise intensity prescription. Conclusions: Exercise-based rehabilitation in patients treated with beta-adrenoceptor antagonists requires an individualized, physiology-guided approach. Cardiopulmonary exercise testing with determination of ventilatory thresholds (VT1 and VT2) should be preferred for exercise prescription. In settings without access to CPET, subjective measures such as the Borg Rating of Perceived Exertion scale and the talk test should be incorporated to ensure safety and training effectiveness.

16 April 2026 in Quality in Sport
Verified
Journal Article
Open access
JKJulia Kaczmarek
Julia Kaczmarek
ODOliwia DziewięCka
Oliwia DziewięCka
DGDominik Gajewski
Dominik Gajewski
ZGZuzanna Głowacka
Zuzanna Głowacka
JGJakub Grandos
Jakub Grandos
WZWojciech ZięBka
Wojciech ZięBka
Peripheral artery disease (PAD) is a common disorder characterised by a reduced blood circulation caused by stenosis or occlusion of peripheral arteries of the limbs, predominantly affecting the lower extremities. This condition is typically related to atherosclerosis, but it might also be caused by vasculitis, fibromuscular dysplasia, or adventitial cystic disease. Although atherosclerotic occlusive disease of the lower extremities has high mortality and morbidity rates, it remains underdiagnosed and undertreated condition. The risk factors of PAD are similar to those for coronary and cerebrovascular disease. The most common symptom of PAD is intermittent claudication, but recent studies show that asymptomatic PAD is several times more common in the population than intermittent claudication. The medical approach to peripheral artery disease is multifaceted and includes smoking cessation, lipid-lowering therapy, antiplatelet therapy, antithrombotic therapy, peripheral vasodilators, blood pressure management, glycemic control and various methods of revascularization. An important, although frequently neglected aspect is an exercise therapy. Walking exercise is first-line therapy for PAD-related walking impairment. Supervised walking exercise and structured home-based walking exercise each not only improve walking ability, but also have other benefits, which we would like to discuss in this review.

15 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AOAgnieszka Olejnik
Agnieszka Olejnik
MMMaria Możdżan
Maria Możdżan
LBLaura Biskup
Laura Biskup
EZEdward Zheng
Edward Zheng
BHBeata Huszcza
Beata Huszcza
KKKinga Kościołek
Kinga Kościołek
Background: The rapid development of Artificial Intelligence (AI) has led to its transition from a theoretical concept in informatics to a functional clinical tool. This study evaluates the impact of AI-based consultants and Large Language Models (LLMs) on patient health literacy and the quality of medical education within the framework of contemporary healthcare standards. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria, 31 key sources were identified and synthesized. Results: LLMs significantly improve the comprehensibility of clinical terminology by adapting medical content to a 9th-11th-grade literacy level. Digital feedback systems, such as the KidneyOnline platform, demonstrate superior efficacy in improving patient adherence compared with standard protocols. However, several critical limitations were identified, including hallucination bias (fabrication of clinical data), a “readability floor” phenomenon associated with up to 83% content reduction, and the risk of professional deskilling among clinicians. Furthermore, wearable devices such as the Apple Watch show high correlation (r=0.92) with medical-grade pulse oximetry, offering new perspectives for real-time health monitoring. Conclusions: AI represents a transformative yet socially consequential innovation in patient education and health literacy. Its responsible implementation requires a strict human-in-the-loop model to ensure clinical safety, ethical accountability, and equitable access. Systematic verification of AI-generated medical information by qualified healthcare professionals remains essential to maintain both high standards of care and public trust in digital health innovations.

14 May 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ZMZofia Janina Możdżan
Zofia Janina Możdżan
AMAdrian Majtas
Adrian Majtas
KGKonrad Gronek
Konrad Gronek
EZEdward Zheng
Edward Zheng
AOAgnieszka Olejnik
Agnieszka Olejnik
LBLaura Biskup
Laura Biskup
Background. Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint destruction, chronic pain, and significant functional impairment. While pharmacological treatment remains the cornerstone of therapy, it is increasingly recognized that optimal patient outcomes require a holistic approach. Non-pharmacological interventions are essential to address the physical, psychological, and social challenges faced by patients. Aim. The aim of this study is to evaluate the effectiveness of various non-pharmacological strategies in the management of RA and to highlight the importance of a coordinated, multidisciplinary team in improving patient quality of life and functional status. Material and methods. A comprehensive review of current clinical guidelines and recent literature (from databases such as PubMed and Scopus) was conducted. The analysis focused on interventions including physical therapy, occupational therapy, nutritional counseling, psychological support, and patient education programs within a multidisciplinary framework. Results. The findings indicate that regular aerobic and resistance exercise, combined with joint protection techniques, significantly reduce pain and fatigue while improving joint mobility. Dietary interventions (e.g., Mediterranean diet) and psychological interventions (e.g., Cognitive Behavioral Therapy) contribute to better disease control and mental well-being. A multidisciplinary approach, involving rheumatologists, physiotherapists, dietitians, and psychologists, leads to higher treatment adherence and better functional outcomes compared to monodisciplinary care. Conclusions. Non-pharmacological management is a vital component of RA care that complements medical treatment. A well-structured, multidisciplinary approach ensures personalized care, targets diverse symptoms, and empowers patients to manage their condition effectively, ultimately leading to a better quality of life.